Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
|
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismProliferation marker protein Ki-67 expression inhibitors |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Faustus Forschungs Cie
0 Patents (Medical) associated with Faustus Forschungs Cie
100 Deals associated with Faustus Forschungs Cie
100 Translational Medicine associated with Faustus Forschungs Cie